Psychemedics Statistics

Total Valuation

Psychemedics has a market cap or net worth of $13.64 million. The enterprise value is $14.18 million.

Market Cap	13.64M
Enterprise Value	14.18M

Important Dates

The next estimated earnings date is Friday, August 9, 2024, after market close.

Earnings Date	Aug 9, 2024
Ex-Dividend Date	n/a

Share Statistics

Psychemedics has 5.81 million shares outstanding. The number of shares has increased by 2.13% in one year.

Shares Outstanding	5.81M
Shares Change (YoY)	+2.13%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	22.70%
Owned by Institutions (%)	20.94%
Float	4.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.63
Forward PS	n/a
PB Ratio	2.17
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.31.

Current Ratio	1.48
Quick Ratio	1.27
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -60.40% and return on invested capital (ROIC) is -35.91%.

Return on Equity (ROE)	-60.40%
Return on Assets (ROA)	-33.00%
Return on Capital (ROIC)	-35.91%
Revenue Per Employee	$186,172
Profits Per Employee	-$38,431
Employee Count	116
Asset Turnover	1.60
Inventory Turnover	n/a

Taxes

In the past 12 months, Psychemedics has paid $981,000 in taxes.

Income Tax	981,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.89% in the last 52 weeks. The beta is 0.69, so Psychemedics's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-47.89%
50-Day Moving Average	2.47
200-Day Moving Average	2.84
Relative Strength Index (RSI)	46.23
Average Volume (20 Days)	3,906

Short Selling Information

The latest short interest is 6,230, so 0.11% of the outstanding shares have been sold short.

Short Interest	6,230
Short Previous Month	9,394
Short % of Shares Out	0.11%
Short % of Float	0.14%
Short Ratio (days to cover)	1.08

Income Statement

In the last 12 months, Psychemedics had revenue of $21.60 million and -$4.46 million in losses. Loss per share was -$0.77.

Revenue	21.60M
Gross Profit	8.33M
Operating Income	-2.96M
Pretax Income	-3.48M
Net Income	-4.46M
EBITDA	-970,000
EBIT	-3.48M
Loss Per Share	-$0.77

Full Income Statement

Balance Sheet

The company has $1.42 million in cash and $1.96 million in debt, giving a net cash position of -$539,000 or -$0.09 per share.

Cash & Cash Equivalents	1.42M
Total Debt	1.96M
Net Cash	-539,000
Net Cash Per Share	-$0.09
Equity (Book Value)	6.28M
Book Value Per Share	1.08
Working Capital	2.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.73 million and capital expenditures -$124,000, giving a free cash flow of -$1.85 million.

Operating Cash Flow	-1.73M
Capital Expenditures	-124,000
Free Cash Flow	-1.85M
FCF Per Share	-$0.32

Full Cash Flow Statement

Margins

Gross margin is 38.57%, with operating and profit margins of -13.70% and -20.64%.

Gross Margin	38.57%
Operating Margin	-13.70%
Pretax Margin	-16.10%
Profit Margin	-20.64%
EBITDA Margin	-4.49%
EBIT Margin	-16.10%
FCF Margin	-8.58%

Dividends & Yields

Psychemedics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.13%
Shareholder Yield	-2.13%
Earnings Yield	-32.68%
FCF Yield	-13.57%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on August 1, 2002. It was a reverse split with a ratio of 1:4.

Last Split Date	Aug 1, 2002
Split Type	Reverse
Split Ratio	1:4

Scores

Psychemedics has an Altman Z-Score of 0.61 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.61
Piotroski F-Score	4